PLUS THERAPEUTICS, INC. — Director's Dealing 2011

Jan 4, 2011

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CYTORI THERAPEUTICS, INC. (CYTX)
CIK: 0001095981
Period of Report: 2011-01-01

Reporting Person: Hawkins Richard J (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2011-01-01	Restricted Stock Award (Common Stock)	A	6000	—	Acquired	10085	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2011-01-01	Non-Qualifed Stock Option (Right to Buy)	$5.19	A	15000	Acquired	2021-01-01	Common Stock (15000)	Direct

Footnotes

F1: The Restricted Stock Award ("Award") vests in full on December 31, 2011, subject to the terms of the Company's 2004 Equity Incentive Plan.

F2: The option vests 1/24th per month from date of grant, subject to the terms of the Company's 2004 Equity Incentive Plan.